久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

Global EditionASIA 中文雙語(yǔ)Fran?ais
Latest News

Pharmaceutical enterprises making innovation faster and more relevant

By He Wei in Shanghai | China Daily | Updated: 2020-07-23 11:43
Share
Share - WeChat
Visitors at the exhibition area of French pharmaceutical giant Sanofi during the second China International Import Expo in Shanghai on Nov 10, 2019. [Photo/Xinhua]

Global pharmaceutical enterprises are looking to boost business operations in China in a bid to make innovation faster and more relevant to the market.

Business executives attribute the upbeat prospects in China to a thriving digital landscape, strong on-the-ground demand for innovation as well as government efforts to cut red tape and encourage technological breakthroughs.

In July, German science and technology conglomerate Merck opened its M Lab Collaboration Center in Shanghai-an in-house facility that fosters new drug development and offers customized solutions from services to training.

Albeit being the ninth such hub worldwide, the one-stop, technology and training center houses 13 labs and claims to be the biggest of its kind for Merck. It boasts four new functionalities including supporting food and beverage security-related inspections as well as environmental industries that are exclusive to the China market.

"The M Lab means faster turnaround, lowered costs as no travel out of China is needed, access to a vast network of biologics and bio-development experts within Merck and enhanced customer convenience," said Steve Vermant, managing director of Merck Life Science China.

For instance, in a dedicated research lab into proteins-the fundamental building block of life sciences-the company provides solutions from protein preparation and analysis to a number of relevant research tools. These stand to provide customers in China with hands-on training and support them on method optimization and application extension.

The existing global network of M Labs has reaped gains across the value chain during the ongoing COVID-19 pandemic, said Ian Carmichael, vice-president and head of bio processing at Merck Life Science China.

"Some of the candidates for drugs or vaccines have been able to accelerate to commercialization because of the work that was done between Merck and the customers in the past. We can go from labs to clinical trials," Carmichael said.

1 2 Next   >>|

Today's Top News

Editor's picks

Most Viewed

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 中文精品爱久久久国产 | 欧美特黄特色aaa大片免费看 | 亚洲在线高清 | 久久精品18 | 国产成人久久777777 | a男人的天堂久久a毛片 | 久久91亚洲精品中文字幕奶水 | 一级毛片免费视频网站 | 久久精品国产99国产精品亚洲 | 男人天堂成人 | 亚洲一级毛片欧美一级说乱 | 国内精品免费一区二区观看 | 亚洲精品中文字幕一区在线 | 欧美精品束缚一区二区三区 | 男人天堂网在线观看 | 亚洲一区在线播放 | 美女视频永久黄网站免费观看国产 | 成人免费视频69 | 欧美亚洲国产精品 | 依依成人综合网 | 97香蕉久久夜色精品国产 | 国产成人精品一区二三区在线观看 | 99re这里只有精品99 | 在线精品国产一区二区 | 国产三级做爰高清在线 | 日韩一区二区三区视频 | 国产三级精品在线观看 | 日韩精品观看 | 男人的天堂欧美精品色偷偷 | 一区二区在线看 | 欧美精品高清在线观看 | 成人亚洲欧美日韩在线 | 国产成人综合95精品视频免费 | 欧美一级大片免费看 | heyzo北条麻妃久久 | 日韩精品一区二区三区不卡 | 久久久久综合给合狠狠狠 | 久久亚洲精品无码观看不卡 | 色综合久久久高清综合久久久 | 一级一级一片免费 | 国产日韩精品一区在线不卡 |